JP2011527984A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527984A5
JP2011527984A5 JP2010549125A JP2010549125A JP2011527984A5 JP 2011527984 A5 JP2011527984 A5 JP 2011527984A5 JP 2010549125 A JP2010549125 A JP 2010549125A JP 2010549125 A JP2010549125 A JP 2010549125A JP 2011527984 A5 JP2011527984 A5 JP 2011527984A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
glucoside
kaempferol
quercetin
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010549125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527984A (ja
Filing date
Publication date
Priority claimed from DE102008012909A external-priority patent/DE102008012909A1/de
Application filed filed Critical
Publication of JP2011527984A publication Critical patent/JP2011527984A/ja
Publication of JP2011527984A5 publication Critical patent/JP2011527984A5/ja
Pending legal-status Critical Current

Links

JP2010549125A 2008-03-06 2009-03-03 虚血性又は炎症性の心疾患及び心臓血管疾患の予防と治療のためのフラボノイド化合物の使用 Pending JP2011527984A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008012909A DE102008012909A1 (de) 2008-03-06 2008-03-06 Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen
DE102008012909.7 2008-03-06
PCT/EP2009/052502 WO2009109573A1 (de) 2008-03-06 2009-03-03 Verwendung von flavonoidverbindungen für die propyhylaxe und therapie ischämischer oder entzündlicher herz- und kreislauferkrankungen

Publications (2)

Publication Number Publication Date
JP2011527984A JP2011527984A (ja) 2011-11-10
JP2011527984A5 true JP2011527984A5 (OSRAM) 2012-04-26

Family

ID=40600026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549125A Pending JP2011527984A (ja) 2008-03-06 2009-03-03 虚血性又は炎症性の心疾患及び心臓血管疾患の予防と治療のためのフラボノイド化合物の使用

Country Status (6)

Country Link
US (2) US20110053874A1 (OSRAM)
EP (1) EP2268277A1 (OSRAM)
JP (1) JP2011527984A (OSRAM)
CA (1) CA2717012A1 (OSRAM)
DE (1) DE102008012909A1 (OSRAM)
WO (1) WO2009109573A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2482864C2 (ru) * 2007-08-31 2013-05-27 Бёрингер Ингельхайм Интернациональ Гмбх Пригодная для распыления композиция, содержащая экстракт из листьев красного винограда
DE102008012908A1 (de) * 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
MX368855B (es) 2012-10-11 2019-10-18 Armaron Bio Pty Ltd Compuestos de flavonoides novedosos y sus usos.
CN113398114B (zh) * 2021-05-28 2022-11-01 浙江大学智能创新药物研究院 3,7,8,4′-四羟基黄酮在制备抗心血管疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271389T1 (de) * 1998-10-29 2004-08-15 Merck Patent Gmbh Zusammensetzung enthaltend eine mischung von bioflavonoiden
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
MXPA02011528A (es) * 2000-05-25 2003-04-25 Pharmaton Sa Metodo para mejorar la proteccion celular.
CN1197567C (zh) * 2002-10-21 2005-04-20 中国人民解放军第二军医大学 山奈酚衍生物用于制备防治脑血管疾病药物的用途
ATE468847T1 (de) 2002-12-31 2010-06-15 Boehringer Ingelheim Int Filmtablette mit extrakt aus roten weinblättern

Similar Documents

Publication Publication Date Title
JP2009537554A5 (OSRAM)
JP2009524695A5 (OSRAM)
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
PT3150198T (pt) Composições farmacêuticas de ácido 3-(6-(1-(2,2 difluorobenzo[d][1,3]dioxol-5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e sua administração
JP2016053040A5 (OSRAM)
JP2013513621A5 (OSRAM)
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
ME02307B (me) Kristalni (r)-(e)-2-(4-(2-(5-(1-(3,5-diklorpiridin-4-il)etoksi)-1h-indazol- 3-il)vinil)-1h-pirazol-1-il)etanol i njegova upotreba kao inhibitora fgfr
BR112012033715A2 (pt) inibidores de quinase de regulação de sinal de apoptose.
NO20090141L (no) Stabiliserte, farmasøytiske preparater som omfatter fesoterodin
AR075179A1 (es) Formulaciones galenicas de compuestos organicos que comprenden alisquireno
WO2009080555A3 (en) Carboxyl- or hydroxyl- substituted benzimidazole derivatives
EA201300159A1 (ru) Использование композиции salvia miltiorrhiza в приготовлении лекарственных препаратов для вторичной профилактики ишемической болезни сердца
WO2011110939A3 (en) Pharmaceutical compositions of substituted benzhydrylpiperazines
PH12018500261A1 (en) Azole benzene derivative
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
JP2022538215A5 (OSRAM)
HRP20171511T1 (hr) Ivabradin-hidroklorid, oblik iv
NO20084998L (no) Tolags tablett for a avverge kardiovaskulaere folger
WO2011029547A8 (en) Isoxazolidine derivatives
JP2015514797A5 (OSRAM)
WO2011138265A3 (en) Indole and indazole derivatives as orexin receptor antagonists
EP2504331A4 (en) COMPOUND, CERTAIN NEW FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS, AND METHOD FOR THEIR PRODUCTION AND USE
JP2008266291A5 (OSRAM)